糖尿病性足潰瘍市場規模・予測（20202030年）、世界・地域シェア、動向、成長機会分析対象範囲潰瘍タイプ（神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍）、治療タイプ（高度創傷ケアドレッシング、生物学的製剤、治療デバイス）、感染重症度（中等度、軽度、重度）、エンドユーザー（病院、外来手術センター、在宅医療）、地域（北米、欧州、アジア太平洋地域、中東・アフリカ、中南米地域）

Diabetic Foot Ulcer Market Size and Forecast (20202030), Global and Regional Share, Trends, and Growth Opportunity Analysis Coverage: Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

世界の糖尿病性足潰瘍市場は、2022年の74億7,060万米ドルから2030年には122億4,277万米ドルに達すると予測される。2022年から2030年までの年平均成長率は6.4%と推定される。市場の成長を促す主な要因は、糖尿... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年9月14日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	231	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

世界の糖尿病性足潰瘍市場は、2022年の74億7,060万米ドルから2030年には122億4,277万米ドルに達すると予測される。2022年から2030年までの年平均成長率は6.4%と推定される。

市場の成長を促す主な要因は、糖尿病とそれに関連する慢性創傷の有病率の高さと老年人口の急増である。しかし、高度な創傷治療には高いコストがかかるため、市場成長の妨げになっている面もある。

糖尿病性足潰瘍市場の市場機会

糖尿病性足潰瘍は慢性創傷の一種であり、しばしば合併症を引き起こし、外科医がそのような傷の管理に苦労する。糖尿病性足潰瘍のような慢性創傷を患う患者数の大幅な増加に伴い、体系的な治療アプローチの必要性が加速しており、創傷治療を効果的なものにするためにエビデンスに基づいた治療の導入が奨励されている。慢性創傷管理に関連するいくつかの研究や臨床試験で、生物活性創傷ケア製品は従来の創傷ケア製品よりも湿潤創傷をより効果的に治癒させることが実証されている。政府機関や研究機関の積極的な参加により、創傷ケア治療の進歩が促進されている。例えば、2021年6月、オーストラリアの臨床段階の幹細胞・再生医療企業であるCynata Therapeutics Limitedは、糖尿病性足潰瘍の臨床試験を進めるため、TekCyte社とライセンス契約を締結した。2021年12月、シナタ・セラピューティクス社により、糖尿病性足潰瘍の治療に使用される同社の間葉系幹細胞製品「サイメルス」の臨床試験が開始された。同様に、2022年6月、スミス+ネフューは、英国のハル郊外に高度創傷管理フランチャイズのための研究開発施設を新設すると発表した。スミス+ネフューは1億米ドル以上を投資し、世界クラスの研究開発施設と柔軟なオフィス環境を整備した。英国政府からの助成金もこの開発を支援している。このように、プレーヤーによる研究活動の活発化とイニシアチブは、市場成長に有利な機会を提供するだろう。

糖尿病性足潰瘍市場の阻害要因

Integra LifeSciences Corporationによると、糖尿病性足潰瘍の治療費は米国の医療制度に莫大な負担をかけており、その額は年間90億～130億米ドルに上る。ハダースフィールド大学が発表したデータによると、医療関連感染（HCAI）、特に手術部位感染（SSI）の治療費は、英国では10億ポンド（～12億6000万米ドル）に上ると推定されている。さらに、糖尿病オーストラリアによると、糖尿病に関連した四肢切断には約23,555米ドルの費用がかかり、術後にはさらに6,065米ドルの年間費用がかかる。5年間で、糖尿病に関連した切断は、社会的コストを除いて、医療システムにとってほぼ50,000米ドルに相当する。創傷の面積や処置の複雑さも治療費を左右する。

糖尿病性足潰瘍の治療費は、インド、中国、韓国などのアジア太平洋諸国でも高い。Elsevier社が2022年に発表した研究によると、中国では糖尿病性足潰瘍の治療費は、切断、入院、治療を含めて1人当たり21,372米ドルである。同様にインドでは、抗生物質、神経障害治療薬、ドレッシング材、コラーゲン・スキャフォールド、成長因子、陰圧創傷治療、手術を含め、1人当たり約19,599米ドルである。このように、先進的な創傷治療には償還制度があるにもかかわらず高額な費用がかかることが、糖尿病性足潰瘍市場の世界的な成長を抑制する主な要因となっている。

糖尿病性足潰瘍市場セグメント別概要

世界の糖尿病性足潰瘍市場は、治療タイプ別に高度創傷被覆材、生物学的製剤、治療機器に区分される。2022年には、高度創傷治療ドレッシング材分野が最大の市場シェアを占めた。従来の方法と比較した場合の高度創傷被覆材の主な利点は、ガーゼとテープの使用に関連している。高度創傷被覆材のこれらの構成要素は、ドレナージに関する問題が少なく治癒を早め、感染を伴うリスクも低い。生物製剤セグメントは2022～2030年に最も高いCAGRを記録すると予測されている。

世界の糖尿病性足潰瘍市場は、潰瘍タイプ別に神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍に区分される。神経虚血性潰瘍セグメントは2022年に最大の市場シェアを占め、同セグメントは2022年から2030年にかけて最も高いCAGRを記録すると予測されている。神経虚血性潰瘍は主に、足、足指、足背の縁、特に足に合わない靴を履いている人の圧迫部位に発生する潰瘍である。このようなタイプの創傷の管理は比較的複雑である。創傷には迅速なケア、適切な靴、オフローディング、ドレッシング材、感染症治療が必要である。神経虚血性潰瘍は最も一般的な糖尿病性足潰瘍（DFU）である。

世界の糖尿病性足潰瘍市場は、感染の重症度別に、中等度、軽度、重度に区分される。2022年の市場シェアは軽症が最も大きく、予測期間中（2022～2030年）のCAGRも軽症が最も高いと予測される。世界の糖尿病性足潰瘍市場をエンドユーザー別に見ると、外来外科センター、病院、在宅医療に区分される。病院セグメントは2022年に最大の市場シェアを占め、同セグメントは2022年から2030年にかけて最も高いCAGRを記録すると予測されている。病院は、複雑だが専門的な科学機器を使って人々に医療サービスを提供する複雑な組織である。病院は、現代医学の問題を教育されたスタッフを任命する。病院は、慢性的で治りにくい傷に悩む患者に高度な治療オプションを提供する。慢性創傷の手術のほとんどは病院で行われるが、これはこれらの施設で術後の継続的な患者ケアとモニタリングが提供されるためである。従って、病院分野は成長すると予想される。

糖尿病性足潰瘍市場地域別概要

北米では、米国が糖尿病性足潰瘍の最大市場であり、主に同国における糖尿病有病率の増加が牽引している。米国足病医学協会（American Podiatric Medical Association）によると、米国では足潰瘍を発症した糖尿病患者の約14～24%が切断を必要としている。健康革新プログラムによると、アメリカでは年間200万人が糖尿病性足潰瘍を発症している。さらに、2022年にNCBIで発表された研究によると、米国の糖尿病患者の〜5％が足潰瘍を発症し、1％が切断に至っている。

この地域における老人人口の増加も市場の成長を後押ししている。2022年に発表された高齢化対策局（米国保健福祉省）の報告書によると、2020年の米国の65歳以上の高齢者人口は5,570万人である。この高齢者層は人口の17％、つまりアメリカ人の6人に1人に相当する。アーバン・インスティテュート（ワシントンDCを拠点とするシンクタンク）の推計によると、65歳以上の人口は今後40年間で倍増し、2040年には8000万人に達するという。さらに、2020年には、糖尿病が65歳以上の成人の主要な慢性疾患のひとつになると考えられている。近年、北米における糖尿病性足潰瘍市場の拡大を加速させるために、いくつかのジョイントベンチャー、イニシアティブ、コラボレーションが貢献している。例えば、2020年には米国の6つの研究機関が米国国立衛生研究所の資金提供を受け、糖尿病性足潰瘍を研究する初の多施設ネットワークを立ち上げた。さらにカナダでは、糖尿病性足合併症の予防を目的としたDiabetic Foot Canadaプログラムが開始された。このように、糖尿病有病率の高さと老年人口の増加が、この地域の市場成長を促進する。

糖尿病性足潰瘍市場に関するレポート作成時に参照した主な一次および二次情報源としては、世界銀行データ、国民保健サービス（NHS）、FDA（食品医薬品局）、EMA（欧州医薬品庁）、WHO（世界保健機関）などがある。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Diabetic Foot Ulcer Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Diabetic Foot Ulcer Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market - Global Market Analysis
6.1 Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
7. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – by Treatment Type
7.1 Overview
7.2 Global Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Ulcer Type
8.1 Overview
8.2 Global Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Infection Severity
9.1 Overview
9.2 Global Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By End User
10.1 Overview
10.2 Global Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: Global Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market - Geographical Analysis
11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1 North America Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.2 North America Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.2.1 North America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.2.2 North America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.2.3 North America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.3 North America Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.4 North America Diabetic Foot Ulcer Market, by End User
11.1.2.5 North America Diabetic Foot Ulcer Market, by Country
11.1.2.6 US
11.1.2.6.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.6.2 US Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.6.3 US Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.6.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.6.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.6.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.6.4 US Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.6.5 US Diabetic Foot Ulcer Market, by End User
11.1.2.7 Canada
11.1.2.7.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.7.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.7.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.7.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.7.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.7.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.7.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.7.5 Canada Diabetic Foot Ulcer Market, by End User
11.1.2.8 Mexico
11.1.2.8.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.8.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
11.1.2.8.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
11.1.2.8.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.2.8.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.2.8.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.2.8.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
11.1.2.8.5 Mexico Diabetic Foot Ulcer Market, by End User
11.2 Europe Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.1 Europe Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.2 Europe Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.2.1 Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.2.2 Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.2.3 Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.3 Europe Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.4 Europe Diabetic Foot Ulcer Market, by End User
11.2.2.5 Europe Diabetic Foot Ulcer Market by Country
11.2.2.6 Germany
11.2.2.6.1 Germany Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.6.2 Germany Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.6.3 Germany Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.6.3.1 Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.6.3.2 Germany: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.6.3.3 Germany: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.6.4 Germany Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.6.5 Germany Diabetic Foot Ulcer Market, by End User
11.2.2.7 UK
11.2.2.7.1 UK Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.7.2 UK Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.7.3 UK Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.7.3.1 UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.7.3.2 UK: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.7.3.3 UK: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.7.4 UK Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.7.5 UK Diabetic Foot Ulcer Market, by End User
11.2.2.8 France
11.2.2.8.1 France Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.8.2 France Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.8.3 France Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.8.3.1 France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.8.3.2 France: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.8.3.3 France: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.8.4 France Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.8.5 France Diabetic Foot Ulcer Market, by End User
11.2.2.9 Italy
11.2.2.9.1 Italy Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.9.2 Italy Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.9.3 Italy Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.9.3.1 Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.9.3.2 Italy: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.9.3.3 Italy: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.9.4 Italy Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.9.5 Italy Diabetic Foot Ulcer Market, by End User
11.2.2.10 Spain
11.2.2.10.1 Spain Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.10.2 Spain Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.10.3 Spain Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.10.3.1 Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.10.3.2 Spain: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.10.3.3 Spain: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.10.4 Spain Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.10.5 Spain Diabetic Foot Ulcer Market, by End User
11.2.2.11 Rest of Europe
11.2.2.11.1 Rest of Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.2.2.11.2 Rest of Europe Diabetic Foot Ulcer Market, by Ulcer Type
11.2.2.11.3 Rest of Europe Diabetic Foot Ulcer Market, by Treatment Type
11.2.2.11.3.1 Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.2.2.11.3.2 Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.2.2.11.3.3 Rest of Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.2.2.11.4 Rest of Europe Diabetic Foot Ulcer Market, by Infection Severity
11.2.2.11.5 Rest of Europe Diabetic Foot Ulcer Market, by End User
11.3 Asia Pacific Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.1 Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.2 Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.2.1 Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.2.2 Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.2.3 Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.3 Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.4 Asia Pacific Diabetic Foot Ulcer Market, by End User
11.3.2.5 Asia Pacific Diabetic Foot Ulcer Market by Country
11.3.2.6 China
11.3.2.6.1 China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.6.2 China Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.6.3 China Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.6.3.1 China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.6.3.2 China: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.6.3.3 China: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.6.4 China Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.6.5 China Diabetic Foot Ulcer Market, by End User
11.3.2.7 Japan
11.3.2.7.1 Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.7.2 Japan Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.7.3 Japan Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.7.3.1 Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.7.3.2 Japan: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.7.3.3 Japan: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.7.4 Japan Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.7.5 Japan Diabetic Foot Ulcer Market, by End User
11.3.2.8 India
11.3.2.8.1 India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.8.2 India Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.8.3 India Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.8.3.1 India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.8.3.2 India: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.8.3.3 India: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.8.4 India Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.8.5 India Diabetic Foot Ulcer Market, by End User
11.3.2.9 Australia
11.3.2.9.1 Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.9.2 Australia Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.9.3 Australia Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.9.3.1 Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.9.3.2 Australia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.9.3.3 Australia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.9.4 Australia Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.9.5 Australia Diabetic Foot Ulcer Market, by End User
11.3.2.10 South Korea
11.3.2.10.1 South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.10.2 South Korea Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.10.3 South Korea Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.10.3.1 South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.10.3.2 South Korea: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.10.3.3 South Korea: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.10.4 South Korea Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.10.5 South Korea Diabetic Foot Ulcer Market, by End User
11.3.2.11 Rest of Asia Pacific
11.3.2.11.1 Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.3.2.11.2 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
11.3.2.11.3 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
11.3.2.11.3.1 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.3.2.11.3.2 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.3.2.11.3.3 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.3.2.11.4 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
11.3.2.11.5 Rest of Asia Pacific Diabetic Foot Ulcer Market, by End User
11.4 Middle East & Africa Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.4 Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.4.1 Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.4.2 Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.4.3 Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.5 Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6 Middle East & Africa Diabetic Foot Ulcer Market, by End User
11.4.6.1 Middle East & Africa Diabetic Foot Ulcer Market by Country
11.4.6.2 UAE
11.4.6.2.1 UAE Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 UAE Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.2.3 UAE Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.2.3.1 UAE: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.2.3.2 UAE: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.2.3.3 UAE: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.2.4 UAE Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.2.5 UAE Diabetic Foot Ulcer Market, by End User
11.4.6.3 Saudi Arabia
11.4.6.3.1 Saudi Arabia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 Saudi Arabia Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.3.3 Saudi Arabia Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.3.3.1 Saudi Arabia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.3.3.2 Saudi Arabia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.3.3.3 Saudi Arabia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.3.4 Saudi Arabia Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.3.5 Saudi Arabia Diabetic Foot Ulcer Market, by End User
11.4.6.4 South Africa
11.4.6.4.1 South Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.4.3 South Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.4.3.1 South Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.4.3.2 South Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.4.3.3 South Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.4.4 South Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.4.5 South Africa Diabetic Foot Ulcer Market, by End User
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Overview
11.4.6.5.2 Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.3 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
11.4.6.5.4 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
11.4.6.5.4.1 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.4.6.5.4.2 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.4.6.5.4.3 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.4.6.5.5 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
11.4.6.5.6 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by End User
11.5 South & Central America Diabetic Foot Ulcer Market, Revenue And Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.1 South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.2 South & Central America Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.2.1 South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.2.2 South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.2.3 South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.3 South & Central America Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.4 South & Central America Diabetic Foot Ulcer Market, by End User
11.5.2.5 South & Central America Diabetic Foot Ulcer Market by Country
11.5.2.6 Brazil
11.5.2.6.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.6.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.6.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.6.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.6.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.6.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.6.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.6.5 Brazil Diabetic Foot Ulcer Market, by End User
11.5.2.7 Argentina
11.5.2.7.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.7.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.7.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.7.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.7.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.7.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.7.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.7.5 Argentina Diabetic Foot Ulcer Market, by End User
11.5.2.8 Rest of South & Central America
11.5.2.8.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.5.2.8.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
11.5.2.8.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
11.5.2.8.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.5.2.8.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.5.2.8.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.5.2.8.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
11.5.2.8.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User
12. Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Diabetic Foot Ulcer Market - Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 URGO MEDICAL Australia Pty Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medline Industries LP
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Organogenesis Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The global diabetic foot ulcer market is expected to reach US$ 12,242.77 million in 2030 from US$ 7,470.60 million in 2022. The market is estimated to grow with a CAGR of 6.4% from 2022 to 2030.

The key factors driving the market's growth are high prevalence of diabetes and related chronic wounds and the surge in geriatric population. However, high cost of advanced wound care treatments is hampering the market's growth to a certain extent.

Market Opportunities of Diabetic Foot Ulcer Market

Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. With the significant growth in the patient pool suffering from chronic wounds, such as diabetic foot ulcers, the need for a systematic treatment approach has accelerated, encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wound management have demonstrated that bioactive wound care products help heal moist wounds more effectively than traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in wound care treatments. For instance, in June 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, signed a license agreement with TekCyte to advance clinical trials in diabetic foot ulcers. In December 2021, a clinical trial on its Cymerus mesenchymal stem cell product used to treat diabetic foot ulcers was launched by Cynata Therapeutics. Similarly, in June 2022, Smith+Nephew announced a new R&D facility for its advanced wound management franchise on the outskirts of Hull, UK. Smith+Nephew invested over US$ 100 million to create a world-class R&D and flexible office environment. A grant from the UK government also supports the development. Thus, the growing research activities and initiative by players will provide lucrative opportunities for the market growth.

Factors Hampering Diabetic Foot Ulcer Market

According to Integra LifeSciences Corporation, the cost of diabetic foot ulcers treatment has an enormous burden on the US healthcare system—ranging between US$ 9 and US$ 13 billion annually. According to the data published by the University of Huddersfield, the cost of treating health care associated infections (HCAIs), particularly surgical site infections (SSIs), has been estimated to represent £1 billion (~US$ 1.26 billion) in the UK. Further, according to Diabetes Australia, diabetes-associated limb amputation costs nearly US$ 23,555, with an additional annual expense of US$ 6,065 post surgery. Over five years, diabetes-related amputation amounts to almost US$ 50,000 for the health system, excluding social costs. The area of a wound and the complexity of procedures also determine the cost of the treatment.

The cost of diabetic foot ulcer treatment is also high in Asia Pacific countries such as India, China, and South Korea. According to a study published in 2022 by Elsevier, the cost of diabetic foot ulcer treatment is ~US$ 21,372/patient in China covering amputations, hospitalizations and medical treatments. Similarly, in India, the cost is around ~US$ 19,599/patient including antibiotics, neuropathic drugs, dressings, collagen scaffolds, growth factors, negative pressure wound therapy, and surgery. Thus, the high cost of advanced wound care treatments, despite the availability of reimbursements, is a key factor restraining the diabetic foot ulcer market growth globally.

Diabetic Foot Ulcer Market: Segmental Overview

The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2022. Major benefits of advanced wound care dressings over traditional methods are associated with the use of gauze and tape. These components of advanced wound care dressings aid in faster healing with fewer issues regarding drainage, and lower risk of accompanying infection. The biologics segment is anticipated to register the highest CAGR during 2022–2030.

The global diabetic foot ulcer market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030. Neuro-ischemia predominately leads to the development of ulcers on the foot, toes, and dorsum margins, especially on pressure sites occurring among people using poorly fitting shoes. The management of such types of wounds is comparatively complex. The wound requires prompt care, appropriate footwear, offloading, dressings, and infection treatment. Neuro-ischemic ulcers are the most common diabetic foot ulcers (DFUs).

The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The mild segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR during the forecast period (2022–2030). The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care. The hospital segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030. Hospitals are complex organizations that provide healthcare services to people using complex but specialized scientific equipment. Hospitals appoint trained staff members that are educated in the problems of modern medical science. Hospitals offer advanced treatment options for patients suffering from chronic and hard-to-heal wounds. Most of the surgeries on chronic wounds are performed in hospitals, owing to the continuous patient care and monitoring offered in these facilities post-surgery. Thus, the hospital segment is expected to grow.

Diabetic Foot Ulcer Market: Geographical Overview

In North America, the US is the largest market for diabetic foot ulcers, primarily driven by the increasing prevalence of diabetes in the country. As per the American Podiatric Medical Association, in the US, nearly 14–24% of patients with diabetes who develop foot ulcers require an amputation. According to the Health Innovation Program, ~2 million people in America develop a diabetic foot ulcer annually. Furthermore, according to a study published in NCBI in 2022, ~5% of patients in the US with diabetes mellitus develop foot ulcers, and 1% end up with an amputation.

The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, In 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above. In recent years, several joint ventures, initiatives, and collaborations contributed in accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.

A few of the major primary and secondary sources referred to while preparing the report on the diabetic foot ulcer market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（ulcers）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（ulcers）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?